Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -8.54MEnterprise Value
VS
Market
Sector
Industry
History
$ 9.25Close
$ 5.09 - $ 94.02 52-Week Range
Ticker Information
Ticker
CNSPCompany Name
CNS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCNS PHARMACEUTICALS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CNSP - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 12.13M | $ 121.77K | $ -8.54M | $ 3.46M |
| 3/31/2025 | $ 13.05M | $ 210.67K | $ -5.95M | $ 6.88M |
| 12/31/2024 | $ 6.46M | $ 326.07K | $ -2.13M | $ 4M |
| 9/30/2024 | $ 6.97M | $ 31.19K | $ -106.78K | $ 6.84M |
| 6/30/2024 | $ 1.49M | $ 123.25K | $ 3.08M | $ 4.45M |
| 3/31/2024 | $ 815.23K | $ 213.1K | $ 1.76M | $ 2.37M |
| 12/31/2023 | $ 548.72K | $ 300.81K | $ 3.57M | $ 3.82M |
| 9/30/2023 | $ 909.55K | $ 41.9K | $ 7.9M | $ 8.77M |
| 6/30/2023 | $ 4.28M | $ 166.4K | $ 3.32M | $ 7.43M |
| 3/31/2023 | $ 5.11M | $ 289.07K | $ 933.17K | $ 5.75M |
Key Performance Insights, Last 5 Years
- CNS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV stands at $ 36.66M.
- Over the past 5 years, CNS PHARMACEUTICALS INC's average EV has been $ 10.76M.
- The median EV for CNS PHARMACEUTICALS INC during this period was $ 2.42M
- CNS PHARMACEUTICALS INC reached its highest EV over the past 5 years at $ 73.09M.
- The lowest EV recorded by CNS PHARMACEUTICALS INC in the same timeframe $ -8.54M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for CNS PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 37.96M ] + Debt [ $ 0 ] - CashnEq [ $ 1.31M ]
(=) EV [ $ 36.66M ] CNSP - Enterprise Value, Last 5 years
$ -8.54M
Minimum
Jun 30, 2025
$ 73.09M
Maximum
Dec 31, 2020
$ 10.76M
Average
$ 2.42M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |